Bulletin 135 - Antipsychotics update
This Antipsychotics bulletin and resources have been updated to include cost effective choices of modified release quetiapine products (for those organisations wishing to use branded generic prescribing). There are two briefings and datapacks to support this bulletin. One is for switching from quetiapine XL to quetiapine immediate release (IR) or cost effective branded products where applicable, and the other a general one which focuses on making local prescribing choices and also includes advice on switching from olanzapine lyophilisates tablets to orodispersible tablets and risperidone orodispersible to standard risperidone tablets as appropriate.
Bulletin 132 Fentanyl (DROP-List) now available to all PrescQIPP users
Fentanyl (DROP-List) is now available to all PrescQIPP users.
Immediate release fentanyl has a NICE do not do as a first line treatment for breakthrough pain. This bulletin which is a DROP list support bulletin will focus on fentanyl immediate-release formulations and provide the rationale for new patients to be commenced on immediate-release morphine, and for current patients to be considered for a switch to immediate-release morphine or have their therapy reviewed and stopped where appropriate. An audit and patient letters are available as supporting resources.
Bulletin 131 Wound care: Topical negative pressure therapy now available to all PrescQIPP users
Wound care: Topical negative pressure therapy is now available to all PrescQIPP users.
Negative pressure wound therapy (NPWT) is increasingly being used as a treatment option for acute, chronic and surgical wounds, and is also being used within community environments. This bulletin will review its place in therapy and focus on ensuring that NPWT is used appropriately, and with minimal wastage.
Wound care - Negative pressure wound therapy
Bulletin 136 Ensuring Appropriate Polypharmacy now available to all PrescQIPP users
Ensuring Appropriate Polypharmacy is now available to all PrescQIPP users.
The second of our polypharmacy and deprescribing bulletins - Ensuring Appropriate Polypharmacy. This bulletin covers a strategic overview of polypharmacy and deprescribing and also has more detailed information and tools to support medication review.
The accompanying Ensuring Appropriate Polypharmacy Tool (flowchart) will be the overarching tool that underpins al our polypharmacy and deprescribing resources.
Polypharmacy - Ensuring Appropriate Polypharmacy
You can also view this amongst the wider range of Polypharmacy materials in the Polypharmacy and Deprescribing Webkit.
Bulletin 125 Tiotropium in asthma now available to all PrescQIPP users
Tiotropium in asthma is now available to all PrescQIPP users.
This resource looks at the place in therapy for tiotropium in asthma and compares to other treatments on the same step of the BTS guidelines. An educational slideset is available as a supporting tool for practice staff training.
Tiotropium in asthma
Bulletin 124 Managed repeats and implementing repeat prescribing now available to all PrescQIPP users
Managed repeats and implementing repeat prescribing is now available to all PrescQIPP users.
This bulletin focuses on repeat dispensing, repeat prescribing, EPS and repeat prescription ordering services. Template training packs for practice staff and patient information letters are available as supporting resources.